RECHEM
Welcome to our website!|Hot Line: 86-21-31433387|E-mail: sales@rechemscience.com
Products Category
Contact Us
| Tel: | +86-21-31433387 |
| +86-15618786686 | |
| Email: | sales@rechemscience.com |
| info@rechemscience.com | |
| QQ: | 1369748377 |
| Skype: | sales@rechemscience.com |
Home > Products
| Cat.No. | Product name | Product Description |
| R2032354 | AZD2932 | AZD2932 is a potent and multi-targeted kinase inhibitor VEGFR2, PDGFβ, Flt-3 and |
| R2032355 | AZD3514 | AZD3514 is a potent and oral androgen receptor downregulator with Ki of 2.2 μM a |
| R2032356 | AZD6482;AZD 6482 (KIN-193) | AZD 6482 (KIN-193) is a potent and selective p110β inhibitor with an IC50 of 0.6 |
| R2032357 | AZD7545 | AZD7545 is a potent, competitive, selective PDHK2 (pyruvate dehydrogenase kinase |
| R2032358 | BAM7 | BAM7 is a direct and selective activator of proapoptotic BAX with an IC50 of 3.3 |
| R2032359 | BAY11-7085;BAY 11-7083 | BAY 11-7085 is an inhibitor of NF-κB activation and phosphorylation of IκBα; it |
| R2032360 | BAY87-2243 | BAY 87-2243 is a highly potent and selective hypoxia-inducible factor-1 (HIF-1) |
| R2032361 | Dactolisib;BEZ235;NVP-BEZ235 | Dactolisib (BEZ235) is a dual pan-class I PI3K and mTOR kinase inhibitor with IC |
| R2032362 | BIBX1382;Falnidamol(BIBX 1382) | Falnidamol (BIBX 1382) is an orally active, selective EGFR tyrosine kinase inhib |
| R2032363 | GSK 3 Inhibitor IX;MLS2052 | GSK 3 Inhibitor IX (6-Bromoindirubin-3'-oxime; BIO) is a potent, selective, reve |
| R2032364 | BIX02189 | BIX02189 is a selective inhibitor of MEK5 with IC50 of 1.5 nM, also inhibits ERK |
| R2032365 | BMS265246 | BMS-265246 is a potent and selective CDK1/2 inhibitor for CDK1/cyclin B and CDK2 |
| R2032366 | BMS345541 | BMS-345541 is a selective inhibitor of the catalytic subunits of IKK (IKK-2 IC50 |
| R2032367 | BMS754807 | BMS-754807 is a potent and reversible inhibitor of IGF-1R/IR with IC50 of 1.8 an |
| R2032368 | AZD1480 | AZD-1480 is an ATP-competitive inhibitor of JAK1 and JAK2 with IC50s of 1.3 and |
| R2032369 | BMS777607;BMS-777607;BMS 817378 | BMS 777607 is a Met-related inhibitor for c-Met, Axl, Ron and Tyro3 with IC50s o |
| R2032370 | BMY7378 Dihydrochloride | BMY 7378 is a multi-targeted inhibitor of α2C-adrenoceptor and α1D-adrenoceptor |
| R2032371 | BRD4770 | BRD4770 is a novel G9a(EHMT2) inhibitor with EC50 of 5 uM (trimethylated H3K9 in |
| R2032372 | BTB06584 | BTB06584 is an IF1-dependent selective inhibitor of the mitochondrial F1Fo-ATPas |
| R2032373 | BX-795 | BX795 is a potent and selective inhibitor of PDK1, with an IC50 of 6 nM.BX795 is |
| R2032374 | BX-912 | BX-912 is a direct, selective, and ATP-competitive PDK1 inhibitor (IC50=26 nM).B |
| R2032375 | Telaglenastat(CB-839) | Telaglenastat (CB-839) is a first-in-class, reversible and orally bioavailable g |
| R2032376 | CCT007093 | CCT007093 is an effective PPM1D inhibitor that selectively reduces viability of |
| R2032377 | Delanzomib(CEP-18770) | Delanzomib(CEP-18770) is a novel orally-active inhibitor of the chymotrypsin-lik |
| R2032378 | CH5132799 | CH5132799 is a selective class I PI3K inhibitor.CH5132799 inhibits class I PI3Ks |
